Sunlab Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.01 Cr
- Revenue Growth 27.88%
- Profit Growth -42.02%
- Ebitda -18.94%
- Net Worth 3.93%
- Total Assets 3.00%
About Sunlab Diagnostics
Sunlab Diagnostics Private Limited (SDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 July 2013 and has a history of 11 years and seven months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.01 Cr.
Anjali Dey, Kaushik Dey, and Premaarwa Kshirsagar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900MH2013PTC245791
- Company No.
245791
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sunlab Diagnostics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Dey  | Director | 17-Jul-2013 | Current |
| Kaushik Dey | Director | 17-Jul-2013 | Current |
| Premaarwa Kshirsagar | Director | 17-Jul-2013 | Current |
Financial Performance of Sunlab Diagnostics.
Sunlab Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.88% increase. The company also saw a substantial fall in profitability, with a 42.02% decrease in profit. The company's net worth moved up by a moderate rise of 3.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunlab Diagnostics?
In 2021, Sunlab Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹20.15 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.76 Cr
- Saraswat Co-Operative Bank : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2018 | Others | ₹5.00 M | Open |
| 08 Sep 2017 | Others | ₹3.85 M | Open |
| 06 Jun 2016 | Others | ₹8.80 M | Open |
| 10 Aug 2015 | Saraswat Co-Operative Bank | ₹2.50 M | Open |
How Many Employees Work at Sunlab Diagnostics?
Unlock and access historical data on people associated with Sunlab Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunlab Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunlab Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
